Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
University of Virginia
Catalysis SL
Seattle Children's Hospital
UNICANCER
Deciphera Pharmaceuticals, LLC
Masonic Cancer Center, University of Minnesota
Ann & Robert H Lurie Children's Hospital of Chicago